Niranjan Sardesai, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), bought 2,550 shares at $8.70 ($22K) on 2014-08-12, disclosed to the SEC on 2014-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INO | BUY | 2013-03-22 | $13K | — | Filing → |
| INO | BUY | 2012-05-17 | $5K | — | Filing → |